Amoeba SA (France) Performance
| ALMIB Stock | EUR 0.77 0.01 1.32% |
On a scale of 0 to 100, Amoeba SA holds a performance score of 13. The firm shows a Beta (market volatility) of 0.34, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Amoeba SA's returns are expected to increase less than the market. However, during the bear market, the loss of holding Amoeba SA is expected to be smaller as well. Please check Amoeba SA's total risk alpha, downside variance, daily balance of power, as well as the relationship between the maximum drawdown and skewness , to make a quick decision on whether Amoeba SA's price patterns will revert.
Risk-Adjusted Performance
13 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Amoeba SA are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Amoeba SA reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 6.7 M | |
| Total Cashflows From Investing Activities | -140.7 K |
Amoeba |
Amoeba SA Relative Risk vs. Return Landscape
If you would invest 54.00 in Amoeba SA on September 5, 2024 and sell it today you would earn a total of 23.00 from holding Amoeba SA or generate 42.59% return on investment over 90 days. Amoeba SA is generating 0.6051% of daily returns and assumes 3.4523% volatility on return distribution over the 90 days horizon. Simply put, 30% of stocks are less volatile than Amoeba, and 88% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Amoeba SA Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Amoeba SA's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Amoeba SA, and traders can use it to determine the average amount a Amoeba SA's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1753
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ALMIB | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.45 actual daily | 30 70% of assets are more volatile |
Expected Return
| 0.61 actual daily | 12 88% of assets have higher returns |
Risk-Adjusted Return
| 0.18 actual daily | 13 87% of assets perform better |
Based on monthly moving average Amoeba SA is performing at about 13% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Amoeba SA by adding it to a well-diversified portfolio.
Amoeba SA Fundamentals Growth
Amoeba Stock prices reflect investors' perceptions of the future prospects and financial health of Amoeba SA, and Amoeba SA fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Amoeba Stock performance.
| Return On Equity | -3.49 | |||
| Return On Asset | -0.29 | |||
| Current Valuation | 40.89 M | |||
| Shares Outstanding | 46.27 M | |||
| Price To Book | 10.62 X | |||
| Price To Sales | 412.48 X | |||
| EBITDA | (4.46 M) | |||
| Cash And Equivalents | 4.97 M | |||
| Cash Per Share | 0.29 X | |||
| Total Debt | 268.74 K | |||
| Debt To Equity | 4.23 % | |||
| Book Value Per Share | 0.15 X | |||
| Cash Flow From Operations | (4.26 M) | |||
| Earnings Per Share | (0.39) X | |||
| Total Asset | 14.52 M | |||
About Amoeba SA Performance
Assessing Amoeba SA's fundamental ratios provides investors with valuable insights into Amoeba SA's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Amoeba SA is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Amoba S.A. develops and sells biocidal and fungicide products. The company was founded in 2010 and is headquartered in Chassieu, France. AMOEBA is traded on Paris Stock Exchange in France.Things to note about Amoeba SA performance evaluation
Checking the ongoing alerts about Amoeba SA for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Amoeba SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Amoeba SA has some characteristics of a very speculative penny stock | |
| Amoeba SA appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (7.82 M) with loss before overhead, payroll, taxes, and interest of (766.61 K). | |
| Amoeba SA has accumulated about 4.97 M in cash with (4.26 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.29. |
- Analyzing Amoeba SA's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Amoeba SA's stock is overvalued or undervalued compared to its peers.
- Examining Amoeba SA's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Amoeba SA's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Amoeba SA's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Amoeba SA's stock. These opinions can provide insight into Amoeba SA's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Amoeba Stock Analysis
When running Amoeba SA's price analysis, check to measure Amoeba SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amoeba SA is operating at the current time. Most of Amoeba SA's value examination focuses on studying past and present price action to predict the probability of Amoeba SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amoeba SA's price. Additionally, you may evaluate how the addition of Amoeba SA to your portfolios can decrease your overall portfolio volatility.